As of 12:44pm ET
| -0.02 / -0.24%|
The 1 analysts offering 12-month price forecasts for Medgenics Inc have a median target of 11.50, with a high estimate of 11.50 and a low estimate of 11.50. The median estimate represents a +40.24% increase from the last price of 8.20.
The current consensus among 1 polled investment analysts is to Buy stock in Medgenics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.